Page 5 of Sun Pharma

Buy these two stocks for medium-term gains while Nifty remains in downtrend

The 20 day SMA also continues to trade below the 50 day SMA, indicating a negative moving average crossover. Weekly…

December 16, 2021 09:04 IST

Titan, Power Grid, SBI, sun pharma, 52-week high, 52-week low

Titan, Power Grid, SBI among 347 stocks to hit 52-week highs on BSE; 19 shares hit 52-week lows

BSE Sensex and Nifty 50 were trading at record high levels on Wednesday, on the back of buying in metal…

October 13, 2021 14:33 IST

Sun Pharma forays into nutrition bar segment with launch of Revital NXT

The market for nutrition bars in India is growing rapidly, with an increasing focus on fitness for a healthy lifestyle.

September 8, 2021 16:32 IST

No plans to get into vaccine production as it requires separate manufacturing infra: Sun Pharma

Commenting on the company’s Halol plant, which has been under the USFDA radar for the last few years, Shanghvi said…

June 13, 2021 14:06 IST

HCL Tech, Sun Pharma, Asian painst, nifty

If Nifty continues to trade below 15,600, it may touch 15,510; HCL Tech, Sun Pharma look strong on charts

The larger texture of the market is still on the bullish side and likely to continue in the near term,…

June 2, 2021 08:56 IST

Sun Pharmaceuticals rating – Buy: One-offs impacted the bottomline in Q4

Steady progress in sales of specialty products; the momentum is likely to be sustained; ‘Buy’ retained with TP raised to…

June 1, 2021 02:15 IST

We raise FY23E EPS by 27% due to core business improvement, gRevlimid and Winlevi. Raise multiple to 28x on consolidated EPS to account for near-term specialty losses that yields revised SOTP-based TP of ₹950.

Sun Pharma Q4 net profit zooms over twofold to Rs 894.15 crore

The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun…

May 27, 2021 19:25 IST

Union Budget 2021, TCS, ICICI Bank, PSU banks

TCS, ICICI Bank, other must-have stocks: Time to rejig investment portfolio post Budget 2021? INTERVIEW

Investment advisor Sandip Sabharwal tells that the biggest driver of the markets now is easy liquidity which needs to be…

February 11, 2021 12:28 IST

Pharma shares regaining momentum, resuming up-trend; here’s how to shape your stock portfolio

Based on technical analysis, ICICI Direct has carved out a list of stocks that makes a multi-cap pharma stock portfolio.

February 4, 2021 13:54 IST

Stocks to buy ahead of Budget 2021: IRCTC, HUL, Maruti, HCL Tech, more; these sectors to be in focus

Union Budget 2021 India: Ahead of Union Budget 2021, market watchers have advised a few sectors and stocks which may…

Updated: January 25, 2021 16:41 IST

stock, divis lab, ipca laboratories, sun pharma

BSE Healthcare index doubles from March lows on COVID vaccine hopes; 3 healthcare stocks look set to gain

Economic indicators have started turning positive which could start the upgrade cycle and liquidity flows across Emerging Markets could remain…

December 15, 2020 15:20 IST

Sun Pharma share price rallies 62% from March lows; should you buy the stock? Check target prices

Sun Pharmaceuticals Industries stock has been on a gaining spree since it touched a 52-week low of Rs 315.20 in…

June 12, 2020 12:52 IST

M-cap of top seven companies decline by Rs 45,963 cr

The combined market valuation of top seven companies declined by Rs 45,962.77 crore last week with IT majors — Infosys…

June 12, 2016 11:58 IST

Sun Pharma enters into derma segment

The company will co-promote Suncros brand across prescription and consumer channels to drive growth Sun Pharma will focus on dermatology…

June 10, 2016 17:58 IST

Sun Pharma announces divestment of US manufacturing units

Divests two units to Frontida BioPharm

June 6, 2016 11:44 IST

Sun Pharma sells two US-based plants to Frontida BioPharm

Drug major Sun Pharmaceutical Industries has sold two of its US-based manufacturing facilities along with 15 products to Frontida BioPharm…

June 4, 2016 19:04 IST

Sun’s problems to linger on for 2-3 quarters: Jefferies

Headwinds plaguing the country’s largest drug-maker Sun Pharmaceutical will continue for next two-three quarters owing to pricing pressures and regulatory…

June 1, 2016 18:57 IST

Sun Pharma revenue growth guidance at 8-10 pc for FY’17

Sun Pharma also said that its board has decided to evaluate a proposal for buyback of equity shares and will…

May 31, 2016 13:56 IST

Related News

Employee quits google job, Google Manager Quits Rs 3.4 Crore Job

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

Tata Capital IPO updates 2025, Tata Capital IPO live allotment status

LIVE: Tata Capital IPO allotment to be finalised today, GMP nears issue price – Step by step guide to check status online

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Powell speech, Powell speech today, US Fed rate cut, inflation, interest rate cut,

All Eyes on Powell: Fed chief to speak today as markets expect more rate cuts

3 ways TCS plans to become world’s largest Al-led tech services company

Business8 min ago

Tata Consultancy Services (TCS), India’s largest information technology company, is heavily investing in AI and data centres in line with the India AI Mission. The company aims to become the world’s largest AI-led technology services company and has announced strategic plans and partnerships to achieve this. TCS has also launched a new entity for AI infrastructure development

View all shorts